A2 Milk has finally got the all clear to sell its infant formula in the U.S.
It applied for the approval back in May when America announced a nationwide shortage, and finally got to break into the market this month.
Adrian Allbon, Jarden's director of equity research, considers this a positive development. The approval process only lasts til January currently, but A2 Milk has an opening to extend their approval and expand their brand into a US market.
LISTEN ABOVE

Katherine Rich: BusinessNZ CEO on the impact NZ First's proposed tax cut for small and medium businesses could have
09:03

Kerre Woodham: Are these election promises worth it to you?
04:37

Campbell Parker: DairyNZ CEO on Fonterra's positive annual result
02:16